Morgan Stanley Glaukos Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Glaukos Corp stock. As of the latest transaction made, Morgan Stanley holds 494,685 shares of GKOS stock, worth $62.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

494,685

Previous 662,501 25.33%

Holding current value

$62.3 Million

Previous $86.3 Million 14.06%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$126.42 - $152.67 $21.2 Million - $25.6 Million	-167,816 Reduced 25.33%	494,685 $74.2 Million
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $5.32 Million - $6.34 Million	46,818 Added 7.6%	662,501 $86.3 Million
Q2 2024 Oct 17, 2024	BUY	$89.48 - $118.35 $5.79 Million - $7.65 Million	64,659 Added 11.73%	615,683 $72.9 Million
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $5.79 Million - $7.65 Million	64,659 Added 11.73%	615,683 $72.9 Million
Q1 2024 Oct 17, 2024	SELL	$76.4 - $96.33 $4.94 Million - $6.23 Million	-64,659 Reduced 10.5%	551,024 $52 Million
Q1 2024 Aug 16, 2024	SELL	$76.4 - $96.33 $8.5 Million - $10.7 Million	-111,232 Reduced 16.8%	551,024 $52 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $8.5 Million - $10.7 Million	-111,232 Reduced 16.8%	551,024 $52 Million
Q4 2023 Aug 16, 2024	BUY	$59.53 - $85.11 $2.77 Million - $3.96 Million	46,573 Added 7.56%	662,256 $52.6 Million
Q4 2023 Feb 13, 2024	SELL	$59.53 - $85.11 $4.05 Million - $5.79 Million	-68,014 Reduced 9.31%	662,256 $52.6 Million
Q3 2023 Nov 15, 2023	BUY	$69.23 - $79.09 $11.2 Million - $12.8 Million	161,775 Added 28.46%	730,270 $55 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $2.9 Million - $4.54 Million	-63,758 Reduced 10.08%	568,495 $40.5 Million
Q1 2023 May 15, 2023	SELL	$43.88 - $52.48 $7.76 Million - $9.29 Million	-176,953 Reduced 21.87%	632,253 $31.7 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $12.1 Million - $17.2 Million	297,021 Added 57.99%	809,206 $35.3 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $256,449 - $320,232	5,475 Added 1.08%	512,185 $27.3 Million
Q2 2022 Oct 27, 2022	SELL	$34.86 - $63.77 $744,574 - $1.36 Million	-21,359 Reduced 4.04%	506,710 $23 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $744,574 - $1.36 Million	-21,359 Reduced 4.04%	506,710 $23 Million
Q1 2022 Oct 27, 2022	BUY	$44.33 - $57.82 $946,844 - $1.23 Million	21,359 Added 4.22%	528,069 $30.5 Million
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $1.09 Million - $1.43 Million	24,676 Added 4.9%	528,069 $30.5 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $1.02 Million - $1.44 Million	-25,256 Reduced 4.78%	503,393 $22.4 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $25.1 Million - $44.5 Million	528,649 New	528,649 $25.5 Million

Others Institutions Holding GKOS

# of Institutions

354

Shares Held

50M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $5.99B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account